You have 9 free searches left this month | to do more
Showing 1176 - 1199 of
1,199 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Completed
  • Intraocular Melanoma
  • Melanoma (Skin)
  • gp100 antigen
  • +2 more
  • Bethesda, Maryland
    Warren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
2013-06-18
Jun 18, 2013
C
Completed
  • Melanoma
  • Sampling of blood
  • Nice, France
    CHU de Nice
2014-06-25
Jun 25, 2014
U
Completed
  • Melanoma
  • MDX-CTLA4 Antibody; Tyrosinase/gp100/MART-1 Peptides Melanoma Vaccine
  • Los Angeles, California
    Universtiy of Southern California/Kenneth Norris, Jr. Comprehens
2014-05-20
May 20, 2014
N
Completed
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
  • +61 more
  • ipilimumab
  • therapeutic allogeneic lymphocytes
  • La Jolla, California
  • +4 more
2013-03-26
Mar 26, 2013
U
Completed
  • Recurrent Head and Neck Cancer
  • IPI-926 and Cetuximab
  • Denver, Colorado
    University of Colorado Denver
2014-01-29
Jan 29, 2014
N
Completed
  • Melanoma (Skin)
  • gp100 antigen
  • +2 more
  • Bethesda, Maryland
    Warren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
2012-06-21
Jun 21, 2012
A
Terminated
  • Prostate Cancer
  • GVAX and ipilimumab
  • Amsterdam, Netherlands
    VU university medical center
2012-01-10
Jan 10, 2012
M
Withdrawn
  • Melanoma
  • Ipilimumab
  • +2 more
  • (no location specified)
2012-01-25
Jan 25, 2012
N
Completed
  • Kidney Cancer
  • ipilimumab
  • Bethesda, Maryland
    Warren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
2012-03-14
Mar 14, 2012
B
Withdrawn
  • Melanoma
  • Los Angeles, California
  • +6 more
2011-11-18
Nov 18, 2011
C
Unknown status
  • Metastatic Melanoma (Stage IIIC Non-résécable or no Surgically Curable or Stage IV With Classification AJCC)
  • Metformin Group
  • Nice, Alpes-Maritimes, France
  • +1 more
2013-04-23
Apr 23, 2013
N
Terminated
  • Melanoma
  • +2 more
  • DMF5 Melanoma Reactive TIL
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2012-10-18
Oct 18, 2012
A
Completed
  • Melanoma
  • Scottsdale, Arizona
  • +7 more
2012-06-05
Jun 5, 2012
A
Completed
  • Malignant Melanoma
  • Los Angeles, California
  • +8 more
2012-06-05
Jun 5, 2012
B
Completed
  • Breast Cancer
  • Adenocarcinoma
  • San Diego, California
  • +13 more
2012-04-26
Apr 26, 2012
B
Completed
  • Melanoma
  • Metastases
  • MDX-010 (anti-CTLA4) monoclonal antibody
  • MDX-1379 (gp100) Melanoma Peptide Vaccine
  • Tucson, Arizona
  • +208 more
2011-06-29
Jun 29, 2011
B
Completed
  • Prostate Cancer
  • MDX-010 / MDX-010 + Docetaxel
  • Tucson, Arizona
  • +10 more
2011-06-23
Jun 23, 2011
N
Completed
  • Anti-p53 TCR-Gene
  • anti-protein 53 or tumor protein 53 (p53) T-cell receptor transduced peripheral blood lymphocytes
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health
2011-08-10
Aug 10, 2011
B
Completed
  • Melanoma
  • MDX-010 (CTLA-4)
  • Tucson, Arizona
  • +8 more
2011-01-20
Jan 20, 2011
B
Completed
  • Intraocular Melanoma
  • Melanoma (Skin)
  • ipilimumab
  • Tyrosinase/gp100/MART-1 Peptides
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute at Universit
2010-04-23
Apr 23, 2010
B
Completed
  • Melanoma
  • ipilimumab (MDX-010, BMS-734016)
  • Ipilimumab
  • Tucson, Arizona
  • +61 more
2010-02-27
Feb 27, 2010
B
Completed
  • Metastatic Melanoma
    • Tuscon, Arizona
    • +10 more
    2010-04-23
    Apr 23, 2010
    B
    Completed
    • Malignant Melanoma
    • MDX-010
    • Tucson, Arizona
    • +3 more
    2010-04-23
    Apr 23, 2010